Literature DB >> 24140674

Increased vasopressin 1A receptor expression in failing human hearts.

Weizhong Zhu1, Douglas G Tilley1, Valerie D Myers1, Emily J Tsai1, Arthur M Feldman2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24140674      PMCID： PMC4243833          DOI： 10.1016/j.jacc.2013.09.032

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

1.  Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gαq-mediated cell signaling.

Authors:  Xue Li; Tung O Chan; Valerie Myers; Ibrul Chowdhury; Xue-Qian Zhang; Jianliang Song; Jin Zhang; Jocelyn Andrel; Hajime Funakoshi; Jeffrey Robbins; Walter J Koch; Terry Hyslop; Joseph Y Cheung; Arthur M Feldman
Journal:  Circulation       Date:  2011-07-11       Impact factor: 29.690

2.  Increased plasma arginine vasopressin levels in patients with congestive heart failure.

Authors:  S R Goldsmith; G S Francis; A W Cowley; T B Levine; J N Cohn
Journal:  J Am Coll Cardiol       Date:  1983-06       Impact factor: 24.094

3.  Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.

Authors:  David E Lanfear; Hani N Sabbah; Steven R Goldsmith; Stephen J Greene; Andrew P Ambrosy; Angela J Fought; Mary J Kwasny; Karl Swedberg; Clyde W Yancy; Marvin A Konstam; Aldo P Maggioni; Faiez Zannad; Mihai Gheorghiade
Journal:  Circ Heart Fail       Date:  2012-12-12       Impact factor: 8.790

4.  Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium.

Authors:  K Asano; D L Dutcher; J D Port; W A Minobe; K D Tremmel; R L Roden; T J Bohlmeyer; E W Bush; M J Jenkin; W T Abraham; M V Raynolds; L S Zisman; M B Perryman; M R Bristow
Journal:  Circulation       Date:  1997-03-04       Impact factor: 29.690

5.  Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.

Authors:  M Böhm; C Mittmann; R H Schwinger; E Erdmann
Journal:  Am Heart J       Date:  1990-12       Impact factor: 4.749
  5 in total
  9 in total

1.  The Bayh-Dole Act, a lion without claws.

Authors:  Arthur M Feldman
Journal:  Clin Transl Sci       Date:  2015-02       Impact factor: 4.689

Review 2.  The role of neuropeptides in adverse myocardial remodeling and heart failure.

Authors:  Alexander Widiapradja; Prasad Chunduri; Scott P Levick
Journal:  Cell Mol Life Sci       Date:  2017-01-17       Impact factor: 9.261

3.  Vasopressin type 1A receptor deletion enhances cardiac contractility, β-adrenergic receptor sensitivity and acute cardiac injury-induced dysfunction.

Authors:  Melissa A Wasilewski; Laurel A Grisanti; Jianliang Song; Rhonda L Carter; Ashley A Repas; Valerie D Myers; Erhe Gao; Walter J Koch; Joseph Y Cheung; Arthur M Feldman; Douglas G Tilley
Journal:  Clin Sci (Lond)       Date:  2016-09-02       Impact factor: 6.124

Review 4.  Arginine vasopressin receptor signaling and functional outcomes in heart failure.

Authors:  Melissa A Wasilewski; Valerie D Myers; Fabio A Recchia; Arthur M Feldman; Douglas G Tilley
Journal:  Cell Signal       Date:  2015-07-30       Impact factor: 4.315

5.  β-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling.

Authors:  Douglas G Tilley; Weizhong Zhu; Valerie D Myers; Larry A Barr; Erhe Gao; Xue Li; Jianliang Song; Rhonda L Carter; Catherine A Makarewich; Daohai Yu; Constantine D Troupes; Laurel A Grisanti; Ryan C Coleman; Walter J Koch; Steven R Houser; Joseph Y Cheung; Arthur M Feldman
Journal:  Circulation       Date:  2014-09-09       Impact factor: 29.690

Review 6.  Cardiovascular Neuroendocrinology: Emerging Role for Neurohypophyseal Hormones in Pathophysiology.

Authors:  Ato O Aikins; Dianna H Nguyen; Obed Paundralingga; George E Farmer; Caroline Gusson Shimoura; Courtney Brock; J Thomas Cunningham
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 4.736

Review 7.  Management of cardiogenic shock complicating acute myocardial infarction: A review.

Authors:  Ashish H Shah; Rishi Puri; Ankur Kalra
Journal:  Clin Cardiol       Date:  2019-03-27       Impact factor: 2.882

Review 8.  The Biology of Vasopressin.

Authors:  Samantha Sparapani; Cassandra Millet-Boureima; Joshua Oliver; Kathy Mu; Pegah Hadavi; Tamar Kalostian; Nazifa Ali; Carla Maria Avelar; Marion Bardies; Brenton Barrow; Minky Benedikt; Giuliana Biancardi; Raminder Bindra; Lisa Bui; Zakaria Chihab; Ashley Cossitt; Jeffrey Costa; Tina Daigneault; Jocelyn Dault; Isa Davidson; Jonathan Dias; Emie Dufour; Sabine El-Khoury; Nargess Farhangdoost; Anika Forget; Alexa Fox; Myriam Gebrael; Maria Concetta Gentile; Olivia Geraci; Ansley Gnanapragasam; Elias Gomah; Elie Haber; Claudia Hamel; Thivya Iyanker; Christina Kalantzis; Sara Kamali; Elsa Kassardjian; Hryssi Krissy Kontos; Thi Bich Uyen Le; Daniella LoScerbo; Yan Fang Low; Danielle Mac Rae; Flore Maurer; Sana Mazhar; Alice Nguyen; Kathy Nguyen-Duong; Chelsea Osborne-Laroche; Hwi Wun Park; Emilie Parolin; Kahlila Paul-Cole; Leah Sarah Peer; Margaux Philippon; Charles-Alexandre Plaisir; Jessica Porras Marroquin; Simran Prasad; Rewaparsad Ramsarun; Saad Razzaq; Samantha Rhainds; Damien Robin; Ryan Scartozzi; Davindra Singh; Sajad Soleimani Fard; Maxim Soroko; Nastaran Soroori Motlagh; Kiri Stern; Laila Toro; M Wyatt Toure; Stephanie Tran-Huynh; Sarah Trépanier-Chicoine; Claudia Waddingham; Aaliyah Jasmine Weekes; Allison Wisniewski; Chiara Gamberi
Journal:  Biomedicines       Date:  2021-01-18

Review 9.  Complementary Role of Oxytocin and Vasopressin in Cardiovascular Regulation.

Authors:  Ewa Szczepanska-Sadowska; Agnieszka Wsol; Agnieszka Cudnoch-Jedrzejewska; Tymoteusz Żera
Journal:  Int J Mol Sci       Date:  2021-10-24       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.